Objective : To explore preferences in the management of patients with newly diagnosed high-risk prostate cancer (PCa) among urologists in Europe through a web-based survey. Materials and Methods : A web-based survey was conducted between 15 August and 15 September 2013 by members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology (EAU). A specific, 29-item multiple-choice questionnaire covering the whole spectrum of diagnosis, staging and treatment of high-risk PCa was e-mailed to all urologists included in the mailing list of EAU members. Europe was divided into four geographical regions: Central-Eastern Europe (CEE), Northern Europe (NE), Southern Europe (SE) and Wes...
Between-country differences in medical and sociodemographic variables, and patient-related outcomes ...
Prostate cancer (PCa)is one of the first three causes of cancer mortality in Europe. Screening in as...
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe. Screening in a...
Objective : To explore preferences in the management of patients with newly diagnosed high-risk pros...
OBJECTIVE: To explore preferences in the management of patients with newly diagnosed high-risk prost...
Introduction: The aim of our survey was to evaluate the usage and indications of various metastatic ...
Open Access via the Elsevier Agreement We are grateful to the EAU Research Foundation for funding th...
BACKGROUND: There is wide variation in prostate cancer incidence and survival across Europe. In man...
OBJECTIVES: Prostate cancer mortality (PCM) in the USA is among the lowest in the world, whereas PCM...
AIMS: To survey current European practices in handling and reporting of radical prostatectomy (RP) s...
A questionnaire was sent to all full‐time British and Irish urologists (n=278) on the management of ...
International audienceBackground. There is wide variation in prostate cancer incidence and survival ...
Background: Guidelines on androgen deprivation therapy (ADT) for prostate cancer (PCa) arise from a ...
Context There is uncertainty regarding the most appropriate criteria for recruitment, monitoring, an...
Active surveillance (AS) has been increasingly proposed as the preferential initial management strat...
Between-country differences in medical and sociodemographic variables, and patient-related outcomes ...
Prostate cancer (PCa)is one of the first three causes of cancer mortality in Europe. Screening in as...
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe. Screening in a...
Objective : To explore preferences in the management of patients with newly diagnosed high-risk pros...
OBJECTIVE: To explore preferences in the management of patients with newly diagnosed high-risk prost...
Introduction: The aim of our survey was to evaluate the usage and indications of various metastatic ...
Open Access via the Elsevier Agreement We are grateful to the EAU Research Foundation for funding th...
BACKGROUND: There is wide variation in prostate cancer incidence and survival across Europe. In man...
OBJECTIVES: Prostate cancer mortality (PCM) in the USA is among the lowest in the world, whereas PCM...
AIMS: To survey current European practices in handling and reporting of radical prostatectomy (RP) s...
A questionnaire was sent to all full‐time British and Irish urologists (n=278) on the management of ...
International audienceBackground. There is wide variation in prostate cancer incidence and survival ...
Background: Guidelines on androgen deprivation therapy (ADT) for prostate cancer (PCa) arise from a ...
Context There is uncertainty regarding the most appropriate criteria for recruitment, monitoring, an...
Active surveillance (AS) has been increasingly proposed as the preferential initial management strat...
Between-country differences in medical and sociodemographic variables, and patient-related outcomes ...
Prostate cancer (PCa)is one of the first three causes of cancer mortality in Europe. Screening in as...
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe. Screening in a...